Imposter syndrome is becoming increasingly common in healthcare and life sciences, affecting leaders at every level. Understanding how it shows

McKinsey’s latest outlook on the US healthcare market is more than a financial projection – it is a guide to

As we wrap up this year, I’ve been reflecting on just how significant – and unusual – it has been

As the sector compresses, strong leaders step forward Healthcare and life sciences are in a cycle of compression and pivot.

In a world where everyone has something to say, standing out isn’t about what you promise. It’s about what you’ve

Boards and executives in healthcare and life sciences face a new reality: to support growth, they need governance that enables

As we enter the second half of the decade, the question facing every board is no longer, “Are we compliant?”

We’re in a period of disruption, but we don’t yet know what that means for the industry. What we do